These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16913845)

  • 1. Transcription factor FOXM1c is repressed by RB and activated by cyclin D1/Cdk4.
    Wierstra I; Alves J
    Biol Chem; 2006 Jul; 387(7):949-62. PubMed ID: 16913845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1/Cdk4 increases the transcriptional activity of FOXM1c without phosphorylating FOXM1c.
    Wierstra I
    Biochem Biophys Res Commun; 2013 Feb; 431(4):753-9. PubMed ID: 23333330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Despite its strong transactivation domain, transcription factor FOXM1c is kept almost inactive by two different inhibitory domains.
    Wierstra I; Alves J
    Biol Chem; 2006 Jul; 387(7):963-76. PubMed ID: 16913846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXM1c is activated by cyclin E/Cdk2, cyclin A/Cdk2, and cyclin A/Cdk1, but repressed by GSK-3alpha.
    Wierstra I; Alves J
    Biochem Biophys Res Commun; 2006 Sep; 348(1):99-108. PubMed ID: 16875671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin E/Cdk2, P/CAF, and E1A regulate the transactivation of the c-myc promoter by FOXM1.
    Wierstra I; Alves J
    Biochem Biophys Res Commun; 2008 Mar; 368(1):107-15. PubMed ID: 18206647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cyclin D1/cyclin-dependent kinase 4 binding site within the C domain of the retinoblastoma protein.
    Pan W; Cox S; Hoess RH; Grafström RH
    Cancer Res; 2001 Apr; 61(7):2885-91. PubMed ID: 11306463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transcription factor FOXM1c is activated by protein kinase CK2, protein kinase A (PKA), c-Src and Raf-1.
    Wierstra I
    Biochem Biophys Res Commun; 2011 Sep; 413(2):230-5. PubMed ID: 21875579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D1 associates with the TBP-associated factor TAF(II)250 to regulate Sp1-mediated transcription.
    Adnane J; Shao Z; Robbins PD
    Oncogene; 1999 Jan; 18(1):239-47. PubMed ID: 9926939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulation of the cyclin D1/Cdk4 retinoblastoma pathway in rat mammary gland carcinomas induced by the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
    Qiu C; Shan L; Yu M; Snyderwine EG
    Cancer Res; 2003 Sep; 63(18):5674-8. PubMed ID: 14522882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the transcription factor FOXM1c by Cyclin E/CDK2.
    Lüscher-Firzlaff JM; Lilischkis R; Lüscher B
    FEBS Lett; 2006 Mar; 580(7):1716-22. PubMed ID: 16504183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the E2F transcription factor by cyclin D1 is blocked by p16INK4, the product of the putative tumor suppressor gene MTS1.
    Schulze A; Zerfass K; Spitkovsky D; Henglein B; Jansen-Dürr P
    Oncogene; 1994 Dec; 9(12):3475-82. PubMed ID: 7970707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression.
    Grillo M; Bott MJ; Khandke N; McGinnis JP; Miranda M; Meyyappan M; Rosfjord EC; Rabindran SK
    Breast Cancer Res Treat; 2006 Jan; 95(2):185-94. PubMed ID: 16319987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The central domain of transcription factor FOXM1c directly interacts with itself in vivo and switches from an essential to an inhibitory domain depending on the FOXM1c binding site.
    Wierstra I; Alves J
    Biol Chem; 2007 Aug; 388(8):805-18. PubMed ID: 17655499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutual requirement of CDK4 and Myc in malignant transformation: evidence for cyclin D1/CDK4 and p16INK4A as upstream regulators of Myc.
    Haas K; Staller P; Geisen C; Bartek J; Eilers M; Möröy T
    Oncogene; 1997 Jul; 15(2):179-92. PubMed ID: 9244353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth inhibition of human MDA-mB-231 breast cancer cells by delta-tocotrienol is associated with loss of cyclin D1/CDK4 expression and accompanying changes in the state of phosphorylation of the retinoblastoma tumor suppressor gene product.
    Elangovan S; Hsieh TC; Wu JM
    Anticancer Res; 2008; 28(5A):2641-7. PubMed ID: 19035289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXM1c transactivates the human c-myc promoter directly via the two TATA boxes P1 and P2.
    Wierstra I; Alves J
    FEBS J; 2006 Oct; 273(20):4645-67. PubMed ID: 16965535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D1/cdk4 can interact with E2F4/DP1 and disrupts its DNA-binding capacity.
    Scimè A; Li L; Ciavarra G; Whyte P
    J Cell Physiol; 2008 Mar; 214(3):568-81. PubMed ID: 17894419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells.
    Bindels EM; Lallemand F; Balkenende A; Verwoerd D; Michalides R
    Oncogene; 2002 Nov; 21(53):8158-65. PubMed ID: 12444551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1b variant promotes cell invasiveness independent of binding to CDK4 in human bladder cancer cells.
    Kim CJ; Nishi K; Isono T; Okuyama Y; Tambe Y; Okada Y; Inoue H
    Mol Carcinog; 2009 Oct; 48(10):953-64. PubMed ID: 19415719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of retinoblastoma protein phosphorylation by myogenesis-induced changes in the subunit composition of the cyclin-dependent kinase 4 complex.
    Wang J; Walsh K
    Cell Growth Differ; 1996 Nov; 7(11):1471-8. PubMed ID: 8930396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.